#bayer
bayer
1,631 ogledov
9 razprav
Vroče
Najnovejše
$ETH baying zone coin it's possible 30k dollar 🔝 💵💰💵💰$ETH #CLARITYActHearingSetforMay14 #JapanOnchainBondsand24/7Trading
$NEIRO
Thursday night ready to go 30.000 sent 📤
#vairal #bayer #Ethereum
$NEIRO
Thursday night ready to go 30.000 sent 📤
#vairal #bayer #Ethereum
شهد الغامدي:
جائزةمني لك تجدها مثبت في اول منشور 🎁
Supreme Court Case Could Reshape Legal Future of Roundup and Glyphosate Claims
A pivotal legal battle is unfolding as the U.S. Supreme Court prepares to hear arguments in a case that could significantly impact thousands of lawsuits against Bayer over its widely used herbicide, Roundup.
At the heart of the case is whether federal regulation by the Environmental Protection Agency overrides state-level claims alleging that the product causes cancer, particularly non-Hodgkin lymphoma. Bayer argues that since the EPA has deemed glyphosate safe and does not require cancer warnings, it should not face liability under state laws. A ruling in Bayer’s favor could effectively dismiss a large portion of ongoing litigation.
However, the case reflects a broader scientific and regulatory divide. While agencies like the EPA maintain that glyphosate is unlikely to be carcinogenic, other bodies, including the International Agency for Research on Cancer, have classified it as “probably carcinogenic,” fueling ongoing public and legal debate.
The outcome carries far-reaching implications, not only for Bayer’s legal exposure but also for U.S. agriculture, where glyphosate remains a cornerstone in crop production. A decision could redefine the balance between federal authority and state-level consumer protection, shaping the future of product liability in regulated industries.
#SupremeCourt #Bayer #Roundup #Glyphosate #LegalNews
$ENSO
$D
$SUI
A pivotal legal battle is unfolding as the U.S. Supreme Court prepares to hear arguments in a case that could significantly impact thousands of lawsuits against Bayer over its widely used herbicide, Roundup.
At the heart of the case is whether federal regulation by the Environmental Protection Agency overrides state-level claims alleging that the product causes cancer, particularly non-Hodgkin lymphoma. Bayer argues that since the EPA has deemed glyphosate safe and does not require cancer warnings, it should not face liability under state laws. A ruling in Bayer’s favor could effectively dismiss a large portion of ongoing litigation.
However, the case reflects a broader scientific and regulatory divide. While agencies like the EPA maintain that glyphosate is unlikely to be carcinogenic, other bodies, including the International Agency for Research on Cancer, have classified it as “probably carcinogenic,” fueling ongoing public and legal debate.
The outcome carries far-reaching implications, not only for Bayer’s legal exposure but also for U.S. agriculture, where glyphosate remains a cornerstone in crop production. A decision could redefine the balance between federal authority and state-level consumer protection, shaping the future of product liability in regulated industries.
#SupremeCourt #Bayer #Roundup #Glyphosate #LegalNews
$ENSO
$D
$SUI
Here's an attractive and engaging post based on your trading setup:
Buy Now: SD 3235–3237
Big move loading!
Entry zone: 3235–3237
Stop-loss: 3225 (risk-managed)
Targets:
3242
3246
3249
3254
Chart aligned. Structure strong.
Let’s ride the momentum!
#StockMarket #TradingSetup #PriceAction #bayer #Trump100Days $XRP $BNB $BTC
Would you like this tailored for a specific platform like Telegram, Twitter, or Instagram?
Buy Now: SD 3235–3237
Big move loading!
Entry zone: 3235–3237
Stop-loss: 3225 (risk-managed)
Targets:
3242
3246
3249
3254
Chart aligned. Structure strong.
Let’s ride the momentum!
#StockMarket #TradingSetup #PriceAction #bayer #Trump100Days $XRP $BNB $BTC
Would you like this tailored for a specific platform like Telegram, Twitter, or Instagram?
Prijavite se, če želite raziskati več vsebin